T. Rowe Price Investment Management, Inc.  and Braidwell LP participate as new investorsStephen Williams, MD, Ph.D. joins as Chief Scientific OfficerRebecca Chambers and Frank Witney, Ph.D. appointed to Board of DirectorsFREMONT, Calif., Jan. 11, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. (”Alamar”), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. ...